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Active Bacterial Core Surveillance (ABCs) Report 
Emerging Infections Program Network 
Neisseria meningitidis, 2011
ABCs Areas 
California (3 county San Francisco Bay area); Colorado (5 
county Denver area); Connecticut; Georgia; Maryland; 
Minnesota; New Mexico; New York (15 county Rochester 
and Albany areas); Oregon; Tennessee (20 counties) 
 
ABCs Population 
The surveillance areas represent 42,421,940 persons. 
Source: National Center for Health Statistics bridged-race 
vintage 2011 postcensal file 
 
ABCs Case Definition 
Meningococcal disease: isolation of Neisseria 
meningitidis from normally sterile site in a resident of a 
surveillance area in 2011.  
 
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that 
include information on demographic characteristics, 
clinical syndrome, and outcome of illness were 
completed for each identified case.  Serogrouping of 
meningococcal isolates was done at CDC and state 
laboratories. Regular laboratory audits assessed 
completeness of active surveillance and detected 
additional cases.  
All rates of  meningococcal disease were calculated using 
population estimates for 2011. For national estimates of 
cases, race- and age-specific rates of disease were applied 
from the aggregate surveillance area to the age and racial 
distribution of the 2011 U.S. population for 49 states 
(excluding Oregon due to an outbreak of serogroup B 
disease). The Oregon reported cases were then added to 
obtain the national estimates. Cases with missing data, 
excluding ethnicity, were multiply imputed using the 
sequential regression imputation method.¶ 
Reported ABCs Profiles 
Race             No.    (Rate*) 
White 82 (0.26) 
Black 18 (0.24) 
Other 4 (0.13) 
Total 104 (0.25) 
* Cases per 100,000 population for ABCs areas 
 Cases Deaths 
Syndrome      No.  (%*) No.  (Rate†) 
Meningitis 43   (41.3) 8   (18.6) 
Bacteremia without focus 26   (25.0) 5    (19.2) 
 
 
 
 
 
 
 
 
* PER CE 
* Percent of cases                                                                                                                          
† Deaths per 100 cases with known outcome 
          
¶
 Surveillance Note 
 At the start of this surveillance year (2011), missing race (n=12) 
data were multiply imputed using sequential regression imputation 
methods. Previously, missing race data were distributed in the same 
proportion as known cases.  
 
 
 
                         Serogroups  
Age B C Y Other‡ 
 (years)    No.  (Rate*)  No.  (Rate*)   No. (Rate*)  No. (Rate*) 
< 1 5 (1.02) 0 (0.00) 4 (0.82) 2 (0.41) 
1  1 (0.20) 0 (0.00) 0 (0.00) 0 (0.00) 
2-4 4 (0.26) 1 (0.07) 1 (0.07) 1 (0.07) 
5-17 1 (0.02) 0 (0.00) 2 (0.03) 1 (0.02) 
18-34 3 (0.03) 7 (0.08) 2 (0.02) 0 (0.00) 
35-49 1 (0.01) 5 (0.06) 2 (0.02) 0 (0.00) 
50-64   5 (0.07) 5 (0.07) 6 (0.08) 1 (0.01) 
≥ 65 1 (0.02) 1 (0.02) 10 (0.21) 3 (0.06) 
Total † 21 (0.05) 19 (0.05) 27 (0.07) 8 (0.02) 
 
Unknown serogroup (n=2) distributed amongst known 
*Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon.  Rates including Oregon are    serogroup B 0.06, 
serogroup C 0.07, serogroup Y 0.09, and serogroup Other 0.03 cases per 
100,000 population for ABCs areas 
‡ Other includes serogroup W-135 and non-groupables 
 
 
Rates of Meningococcal Disease in Adolescents and 
Young Adults† 
 
Overall 
Serogroups 
C/Y/W-135 
Serogroups 
Age (years)        No.  (Rate*)       No.  (Rate*) 
11-17 2 (0.06) 1 (0.03) 
18-22 4   (0.15)  4 (0.15)  
 
* Cases per 100,000 population for ABCs areas excluding Oregon 
† All rates exclude Oregon.  Rates including Oregon are, for 11-17 year 
olds, overall serogroups 0.10 and serogroup C/Y/W-135 0.08; for 18-22 
year olds, overall serogroups 0.27 and serogroup C/Y/W-135 0.27 cases per 
100,000 population for ABCs areas 
 
National Estimates for Disease
 ¥
 
 Cases:         620    (0.20/100,000)    
 Deaths:       100    (0.03/100,000) 
 
¥ In 2011, 845 cases of meningococcal disease (all case statuses) were 
reported to the National Notifiable Disease Surveillance System 
(incidence 0.27/100,000 population) 
 
Healthy People 2020 Update 
Objective: Reduce the incidence of meningococcal 
disease to 0.3 per 100,000 population. 
2020 Objective 2011 Rate*  
0.3/100,000     0.20/100,000  
* Cases per 100,000 U.S. population  
 
For more information, visit our web site: 
 http://www.cdc.gov/abcs  
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